参考文献/References:
［1］ PIRAM M,MALDINI C,BISCARDI S,et al.Incidence of IgA vasculitis in children estimated by four-source capture-recapture ana-lysis：a population-based study［J］.Rheumatology (Oxford),2017,56(8):1358-1366.
［2］ MOSSBERG M，SEGELMARK M,KAHN R,et al.Epidemiology of primary systemic vasculitis in children：a population-based study from southern Sweden［J］.Scand J Rheumatol,2018,47(4):295-302.
［3］ WALLER R,AHMED A,PATEL I.Update on the classification of vasculitis［J］.Best Pract Res Clin Rheumatol,2013,27(1):3-17.
［4］ DAVIN J C,COPPO R.Henoch-Schnlein purpura nephritis in children［J］.Nat Rev Nephrol.Nephrology,2014,10(10):563-573.
［5］ PILLEBOUT E,THERVET E,HILL G,et al.Henoch-Schnlein purpura in adults：outcome and prognostic factors［J］.J Am Soc Nephrol,2002,13(5):1271-1278.
［6］ LI L S,LIU Z H.Epidemiologic data of renal diseases from a single unit in China：analysis based on 13 519 renal biopsies［J］.Kidney Int,2004,66(3):920-923.
［7］ SUZUKI H，YASUTAKE J，MAKITA Y,et al.IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis［J］.Kidney Int,2018,93(3):700-705.
［8］ HUANG X,WU X,LE W,et al.Renal prognosis and related risk factors for Henoch-Schnlein purpura nephritis：a Chinese adult patient cohort［J］.Sci Rep,2018,8(1):5585.
［9］ COPPO R.Clinical and histological risk factors for progression of IgA nephropathy：an update in children，young and adult patients［J］.J Nephrol,2017,30(3):339-346.
［10］ COPPO R,ANDRULLI S,AMORE A,et al.Predictors of outcome in Henoch-Schnlein nephritis in children and adults［J］.Am J Kidney Dis,2006,47(6):993-1003.
［11］ COUNAHAN R,WINTERBORN M H,WHITE R H,et al.Prognosis of Henoch-Schnlein nephritis in children［J］.Br Med J,1977,2(6078):11-14.
［12］ CRAGO S S,KUTTEH W H,MORO I,et al.Distribution of IgA1-，IgA2-，and J chain-containing cells in human tissues［J］.J Immunol,1984,132(1):16-18.
［13］ HEINEKE M H,BALLERING A V,JAMIN A,et al.New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schnlein purpura)［J］.Autoimmun Rev,2017,16(12):1246-1253.
［14］ TAKAHASHI K，WALL S B，SUZUKI H，et al.Clustered O-glycans of IgA1：defining macro- and microheterogeneity by use of electron capture/ transfer dissociation ［J］.Mol Cell Proteomics，2010，9(11)：2545-2557.
［15］ KIRYLUK K，MOLDOVEANU Z，SANDERS J T,et al.Aberrant glycosylation of IgA1 is inherited in pediatric IgA nephropathy and Henoch-SchnleinPurpura nephritis［J］.Kidney Int,2011，80:79-87.
［16］ MOURA I C,CENTELLES M N,ARCOS-FAJARDO M,et al.Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy［J］.J Exp Med,2001,194(4):417-425.
［17］ KNOPPOVA B,REILY C,MAILLARD N,et al.The origin and activities of IgA1-containing immune complexes in IgA nephropathy［J］.Front Immunol,2016,7:117.
［18］ DAVIN J C，TEN BERGE I J，WEENING J J.What is the diffe-rence between IgA nephropathy and Henoch-Schnlein purpura nephritis［J］.Kidney Int,2001,59(3):823-834.
［19］ SUZUKI H,RASKA M,YAMADA K,et al.Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes［J］.J Biol Chem,2014,289(8):5330-5339.
［20］ 王芳.IgA1糖基化异常在儿童紫癜性肾炎中致病机制的研究［J］.国际儿科学杂志,2018,45(10):789-793.
［21］ NOVAK J,BARRATT J,JULIAN B A,et al.Aberrant glycosylation of the IgA1 molecule in IgA nephropathy［J］.Semin Nephrol,2018,38(5):461-476.
［22］ GUO Y N，WANG Z，LU J.The relationship between children kidney diseases and adult ESRD：an epidemiological investigation of 700 cases［J］.Ren Fail,2013,35(10):1353-1357.
［23］ SCHRER K,KRMAR R,QUERFELD U,et al.Clinical outcome of Schnlein-Henoch purpura nephritis in children［J］.Pediatr Nephrol,1999,13(9):816-823.
［24］ XU K,ZHANG L,DING J,et al.Value of the Oxford classification of IgA nephropathy in children with Henoch-Schnlein purpura nephritis［J］.J Nephrol,2018,31(2):279-286.
［25］ HUANG X,MA L,REN P,et al.Updated Oxford classification and the international study of kidney disease in children classification：application in predicting outcome of Henoch-Schnlein purpura nephritis［J］.Diagn Pathol,2019,14(1):40.
［26］ KOSKELA M,YLINEN E,UKONMAANAHO E M,et al.The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schnlein purpura nephritis［J］.Pediatr Nephrol,2017,32(7):1201-1209.
［27］ JELUSIC M，SESTAN M，CIMAZ R，et al.Different histological classifications for Henoch-Schnlein purpura nephritis：which one should be used［J］.Pediatr Rheumatol Online J，2019,17(1):10.
［28］ KIM C H,LIM B J,BAE Y S,et al.Using the Oxford classification of IgA nephropathy to predict long-term outcomes of Henoch-Schnlein purpura nephritis in adults［J］.Mod Pathol,2014,27(7):972-982.
［29］ YUN D,KIM D K,OH K H,et al.MEST-C pathological score and long-term outcomes of child and adult patients with Henoch-Schnlein purpura nephritis［J］.BMC Nephrol,2020,21(1):33.
［30］ MAGISTRONI R,D′AGATI V D,APPEL G B,et al.New deve-lopments in the genetics，pathogenesis，and therapy of IgA nephropathy［J］.Kidney Int,2015,88(5):974-989.
［31］ HAAS M.Histologic subclassification of IgA nephropathy：a clinicopathologic study of 244 cases［J］.Am J Kidney Dis,1997,29(6):829-842.
［32］ LEE S M,RAO V M,FRANKLIN W A,et al.IgA nephropathy：morphologic predictors of progressive renal disease［J］.Hum Pathol,1982,13(4):314-322.
［33］ KATAFUCHI R，KIYOSHI Y，OH Y，et al.Glomerular score as a prognosticator in IgA nephropathy：its usefulness and limitation［J］.Clin Nephrol，1998,49(7):1-8.
［34］ WORKING GROUP OF THE INTERNATIONAL IGA NEPHROPATHY NETWORK AND THE RENAL PATHOLOGY SOCIETY,ROBERTS I S,COOK H T,et al.The Oxford cla-ssification of IgA nephropathy：pathology definitions，correlations，and reproducibility［J］.Kidney Int,2009,76(5):546-556.
［35］ TRIMARCHI H,BARRATT J,CATTRAN D C,et al.Oxford cla-ssification of IgA nephropathy 2016：an update from the IgA Nephropathy Classification Working Group［J］.Kidney Int,2017,91(5):1014-1021.
［36］ CAI Q,SHI S,WANG S,et al.Microangiopathic lesions in IgA nephropathy：a cohort study［J］.Am J Kidney Dis,2019,74(5):629-639.
［37］ DAVIN J C，COPPO R.Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Schnlein purpura nephritis［J］.Pediatr Nephrol,2013,28(10):1897-1903.
［38］ LI X,TANG M,YAO X,et al.A clinicopathological comparison between IgA nephropathy and Henoch-Schnlein purpuranephritis in children:useof the Oxford classification［J］.Clin Exp Nephrol,2019,23(12):1382-1390.
［39］ 张小芬,卫建平,吴丽然,等.过敏性紫癜性肾炎与IgA肾病临床及病理的对比研究［J］.中国现代医药杂志,2008,10(4):14-16．
［40］ 华冉,鹿玲.儿童紫癜性肾炎与IgA肾病关系研究进展［J］.国际儿科学杂志,2016,43(1):14-17.
［41］ 郭宏湘,张建江,史佩佩,等.儿童紫癜性肾炎和IgA肾病临床病理对比分析［J］.中国当代儿科杂志,2012,14(7):506-509.
相似文献/References:
[1]潘笑悦,杨达胜,赵德安,等. 儿童紫癜性肾炎流行病学、发病机制及相关生物学指标研究进展 [J].新乡医学院学报,2015,32(04):364.[doi:10.7683/xxyxyxb.2015.04.022]
[2]马媛媛,姬 萌,郭醉爽,等.昆仙胶囊治疗原发性IgA肾病疗效观察[J].新乡医学院学报,2021,38(10):961.[doi:10.7683/xxyxyxb.2021.10.013]
MA Yuanyuan,JI Meng,GUO Zuishuang,et al.Effect of Kunxian capsule in the treatment of primary IgA nephropathy[J].Journal of Xinxiang Medical University,2021,38(4):961.[doi:10.7683/xxyxyxb.2021.10.013]
[3]郭庆寅,丁 樱,郭 婷,等.儿童孤立性血尿型紫癜性肾炎135例临床分析[J].新乡医学院学报,2018,35(6):531.[doi:10.7683/xxyxyxb.2018.06.021]
GUO Qing-yin,DING Ying,GUO Ting,et al.Analysis of the clinical features of isolated hematuria Henoch-Schonlein purpura nephritis of children in 135 cases[J].Journal of Xinxiang Medical University,2018,35(4):531.[doi:10.7683/xxyxyxb.2018.06.021]
[4]张艳敏,宋晓翔,封其华.他克莫司治疗儿童紫癜性肾炎疗效观察[J].新乡医学院学报,2017,34(9):815.[doi:10.7683/xxyxyxb.2017.09.009]
ZHANG Yan-min,SONG Xiao-xiang,FENG Qi-hua.Clinical effect of tacrolimus for Henoch-Schnlein purpura nephritis in children[J].Journal of Xinxiang Medical University,2017,34(4):815.[doi:10.7683/xxyxyxb.2017.09.009]
[5]姚俊东,刘彬彬,王运昌,等.超微血流成像联合声脉冲辐射力弹性成像对IgA肾病的诊断价值[J].新乡医学院学报,2022,39(7):637.[doi:10.7683/xxyxyxb.2022.07.008]
YAO Jundong,LIU Binbin,WANG Yunchang,et al.Value of superb microvascular imaging combined with aoustic radiation force impulse in diagnosis of IgA nephropathy[J].Journal of Xinxiang Medical University,2022,39(4):637.[doi:10.7683/xxyxyxb.2022.07.008]
[6]孙晓莉,郭永兵.小剂量泼尼松联合他克莫司治疗老年IgA肾病疗效观察[J].新乡医学院学报,2022,39(8):756.[doi:10.7683/xxyxyxb.2022.08.011]
SUN Xiaoli,GUO Yongbing.Effect of low-dose prednisone combined with tacrolimus in the treatment of elderly patients with IgA nephropathy[J].Journal of Xinxiang Medical University,2022,39(4):756.[doi:10.7683/xxyxyxb.2022.08.011]
[7]李智恒,文青,蔡雪妮,等.IgA肾病治疗研究进展[J].新乡医学院学报,2023,40(3):295.[doi:10.7683/xxyxyxb.2023.03.019]
LI Zhiheng,WEN Qing,CAI Xueni,et al.Research progress in the treatment of IgA nephropathy[J].Journal of Xinxiang Medical University,2023,40(4):295.[doi:10.7683/xxyxyxb.2023.03.019]
[8]方红星,胡祖霞,张涛,等.过敏性紫癜患儿继发肾损害的危险因素分析[J].新乡医学院学报,2023,40(9):856.[doi:10.7683/xxyxyxb.2023.09.010]
FANG Hongxing,HU Zuxia,ZHANG Tao,et al.Risk factors of secondary renal damage in children with Henoch-Schonlein purpura[J].Journal of Xinxiang Medical University,2023,40(4):856.[doi:10.7683/xxyxyxb.2023.09.010]